ghk-cu tolerance or loss of effectiveness over time desensitization long-term use The tri-peptide complex ameliorates lipopolysaccharide-induced acute lung injury in mice Exploring the beneficial effects – GHK-Cu Topical Serum: Benefits, Mechanism

Significant Unknowns Because no human-approved protocols exist, major uncertainties remain: whether localized vs systemic models produce different outcomes how timing affects various tissue types how combined administration influences biological pathways long-term safety implications of repeated dosing optimal duration, interval, or amount for any experimental purpose These unknowns highlight the experimental nature of all administration approaches described in preclinical settings

Maintenance therapy : Following the loading phase, 1 mg every two to three months for life in cases of pernicious anaemia or malabsorption

yielding 16 possible goal locations

Drug Interactions: The clinical trials did not specifically evaluate interactions between AOD-9604 and other medications